Curium in Finland
E-mail: orders.finland@curiumpharma.com
Web: https://www.curiumfinland.fi/
Addresses:
-
Office 1 Curium in Finland
Kivihaka (MAP), MAP Medical Technologies Oy, Kivihaantie 7 F, FI-00310 Helsinki
Phone: +358 14 334 5211
-
Office 2 Curium in Finland
Tikkakoski (MAP), MAP Medical Technologies Oy, Elementtitie 27, FI-41160 Tikkakoski
Phone: +358 14 334 5211
Other Curium's locations around the world
Clinical Trials sponsored by Curium
-
Curium US LLCActief, niet wervendMetastase van kwaadaardige prostaattumorVerenigde Staten, Frankrijk, Spanje, Italië
-
Curium US LLCWervingProstaatkanker | Prostaat Adenocarcinoom | Biochemische herhaling van kwaadaardig neoplasma van de prostaatVerenigde Staten
-
Curium US LLCWervingProstaatkanker | Prostaat AdenocarcinoomVerenigde Staten
-
Curium US LLCVoltooidMetastase van kwaadaardige prostaattumor (aandoening)Verenigde Staten
-
Curium PET FranceActief, niet wervendProstaatkanker terugkerendFrankrijk
-
Curium US LLCGoedgekeurd voor marketingNeuro-endocriene tumoren
-
Weill Medical College of Cornell UniversityCurium US LLCNog niet aan het wervenMeningeoomVerenigde Staten
About Curium
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products to customers around the globe. Drawing on years of proven experience, we aim to drive the nuclear medicine industry forward through excellence, reliability and unparalleled service. We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation. Curium specialises in the production and supply of radioactive tracers used in nuclear medicine. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, our world-class products empower our customers with effective treatment, and proven patient outcomes.